On April 30, 2019 Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs, reported a poster presentation at ARVO 2019 Annual Meeting in Vancouver, British Columbia (Press release, Exicure, APR 30, 2019, View Source [SID1234535469]). The poster is titled "Spherical Nucleic Acids Exhibit Enhanced Distribution and Persistence Compared to Linear Oligonucleotides in Rat Eyes Following Intravitreal Administration" and will be presented by Bart Anderson, Director of R&D at Exicure.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Session Date/Times: Tuesday, April 30, 2019 from 11:45 am to 1:30 pm PDT and 4:30 pm to 5:30 pm PDT

Presentation number: 3378, Poster board number A0148

Session track: Drug delivery, drug and gene delivery system, implant delivery